No complaints with the Lobster. But few foods beat the scent of Italian-grilled Porterhouse Steak with all the trimmings,
Anyone who really knows this company, as well as the stock ... knows that few stocks have been more punished for the company making nothing but perfect moves for two years. If you have a brain you want to load up and hold on. No bull .. no pump.
Sentiment: Strong Buy
May 6, 2013 .....The American Association of Clinical Endocrinology, or AACE, stated in its new guidelines for the treatment of type 2 diabetes and prediabetes that doctors should consider using "obesity management" techniques to treat these patients. The AACE's new guidelines are likely to support increased use of approved anti-obesity drugs among type 2 diabetes patients, The association's diabetes guidelines issued in 2009 did not include any statements on obesity, and the change is likely to cause more insurance companies to cover anti-obesity drugs, Leerink Swann analyst Marko Kozul believes that the AACE's statements will meaningfully increase doctors' use of Iorcaserin, an anti-obesity treatment developed by Arena Pharmaceuticals (ARNA),
Wall Street wants this stock so bad they will do everything except use gun play to get it,